What is Avelox®?

The antibiotic moxifloxacin, a fluoroquinolone agent, is marketed under several brand names, including Avelox® and Vigamox®. Avelox® is a treatment for bacterial infections of the skin and sinuses as well as bronchitis, pneumonia, and conjunctivitis. This drug is available as eye drops, in tablet form, and as an intravenous solution. Moxifloxacin can cause severe side effects, such as liver failure, neuropathy, and tendinitis, and is known to interact with other drugs like acenocoumarol and common nutritional supplements, including calcium, magnesium, and zinc. As a result, Avelox® is considered to be a treatment option of last resort when other antibiotics have failed.

This antibiotic was developed by Bayer and first marketed in the United States in 1999. It is a broad-spectrum antibiotic that works by inhibiting cell replication. It is most commonly taken orally in tablet form with water for between five and 21 days depending on the type and severity of the infection. Avelox® should be taken as directed for as long as directed in order to avoid bacterial resistance.

Serious bacterial infections like bronchitis, pneumonia, and tuberculosis are treated with Avelox® when other antibiotics have failed. Sinus infections, endocarditis, and bacterial infections of the skin, especially in the stomach area, can be treated with this drug. It is also a treatment option for individuals infected with anthrax. The eye drop form of moxifloxacin is sometimes given to patients with bacterial conjunctivitis or pink eye.

There are few approved uses of Avelox® because of the drug’s potential to cause severe side effects. Common side effects are gastrointestinal like nausea, constipation, and heartburn. Sores and white patches in the mouth are also possible.

More serious side effects include months of severe diarrhea, rashes, and blistering skin. Neuropathy, liver damage, and tendinitis can also result from treatment. Patients may also experience mental problems like depression, suicidal thoughts, and hallucinations.

Avelox® can cause joint and bone problems in children and should not be prescribed to anyone less than the age of 18. This drug is known to interact with blood thinners like warfarin, some antidepressants and anti-psychotics, and nonsteroidal anti-inflammatory drugs such as ibuprofen. Avelox® can also interact with common nutritional supplements like iron and zinc.

Like any antibiotic, Avelox® is not effective against influenza, colds, or other viral infections. Taking an antibiotic for a viral infection or failing to finish the course of antibiotics as directed by a medical professional can contribute to the problem of bacterial resistance. Bacteria that develop resistance to antibiotics can mean that there will be fewer effective treatment options available for those who become infected.